Abstract:Myopia is prevalent worldwide, particularly in East and Southeast Asia. Recent studies have suggested that the spectral composition of ambient lighting in uences refractive development, especially in humans. We aimed to determine the effect of 650-nm single-wavelength red light on the inhibition of myopia progression in children. In this retrospective cohort study, 105 myopic children (spherical equivalent refractive error [SER], -6.75 to -1.00 dioptres (D)) aged from 4 to 14 years old were retrospectively rev… Show more
“… 16 – 18 This study result aligns with previous findings, with AL changes of −0.01 mm at 6 months and 0.08 mm at 1 year in the RLRL group. Refraction changes were also similar, with SER changes of 0.29 D at 6 months and 0.05 D at 6 to 12 months, similar to the results for the studies by Jiang et al 16 (−0.03 D and 0.20 D, respectively) and Zhou et al 17 (0.19 D at 6 months). The continuity of such promising results reinforces the notion that RLRL is an effective treatment for AL and refraction in myopes.…”
Section: Discussionsupporting
confidence: 88%
“… 16 A similar effect was observed after a 9-month follow-up in a retrospective study. 17 When Xiong et al 18 compared RLRL with orthokeratology, a more profound effect on axial length (AL) control was evident after RLRL treatment for 6 months. In these studies, a 650-nm, single-wavelength red light was used, and the protective effect appears to be associated with an increase in choroidal thickness.…”
Purpose
To compare the treatment efficacy between repeated low-level red light (RLRL) therapy and 0.01% atropine eye drops for myopia control.
Methods
A single-masked, single-center, randomized controlled trial was conducted on children 7 to 15 years old with cycloplegic spherical equivalent refraction (SER) ≤ −1.00 diopter (D) and astigmatism ≤ 2.50 D. Participants were randomly assigned to the RLRL group or low-dose atropine (LDA, 0.01% atropine eye drops) group and were followed up at 1, 3, 6, and 12 months. RLRL treatment was provided by a desktop light therapy device that emits 650-nm red light. The primary outcome was the change in axial length (AL), and the secondary outcome was the change in SER.
Results
Among 62 eligible children equally randomized to each group (31 in the RLRL group, 31 in the LDA group), 60 children were qualified for analysis. The mean 1-year change in AL was 0.08 mm (95% confidence interval [CI], 0.03–0.14) in the RLRL group and 0.33 mm (95% CI, 0.27–0.38) in the LDA group, with a mean difference (MD) of −0.24 mm (95% CI, −0.32 to −0.17;
P
< 0.001). The 1-year change in SER was −0.03 D (95% CI, −0.01 to −0.08) in the RLRL group and −0.60 D (95% CI, −0.7 to −0.48) in the LDA group (MD = 0.57 D; 95% CI, 0.40–0.73;
P
< 0.001). The progression of AL < 0.1 mm was 53.2% and 9.7% (
P
< 0.001) in the RLRL and LDA groups, respectively. For AL ≥ 0.36 mm, progression was 9.7% and 50.0% (
P
< 0.001) in the RLRL and LDA groups, respectively.
Conclusions
In this study, RLRL was more effective for controlling AL and myopia progression over 12 months of use compared with 0.01% atropine eye drops.
Translational Relevance
RLRL therapy significantly slows axial elongation and myopia progression compared with 0.01% atropine; thus, it is an effective alternative treatment for myopia control in children.
“… 16 – 18 This study result aligns with previous findings, with AL changes of −0.01 mm at 6 months and 0.08 mm at 1 year in the RLRL group. Refraction changes were also similar, with SER changes of 0.29 D at 6 months and 0.05 D at 6 to 12 months, similar to the results for the studies by Jiang et al 16 (−0.03 D and 0.20 D, respectively) and Zhou et al 17 (0.19 D at 6 months). The continuity of such promising results reinforces the notion that RLRL is an effective treatment for AL and refraction in myopes.…”
Section: Discussionsupporting
confidence: 88%
“… 16 A similar effect was observed after a 9-month follow-up in a retrospective study. 17 When Xiong et al 18 compared RLRL with orthokeratology, a more profound effect on axial length (AL) control was evident after RLRL treatment for 6 months. In these studies, a 650-nm, single-wavelength red light was used, and the protective effect appears to be associated with an increase in choroidal thickness.…”
Purpose
To compare the treatment efficacy between repeated low-level red light (RLRL) therapy and 0.01% atropine eye drops for myopia control.
Methods
A single-masked, single-center, randomized controlled trial was conducted on children 7 to 15 years old with cycloplegic spherical equivalent refraction (SER) ≤ −1.00 diopter (D) and astigmatism ≤ 2.50 D. Participants were randomly assigned to the RLRL group or low-dose atropine (LDA, 0.01% atropine eye drops) group and were followed up at 1, 3, 6, and 12 months. RLRL treatment was provided by a desktop light therapy device that emits 650-nm red light. The primary outcome was the change in axial length (AL), and the secondary outcome was the change in SER.
Results
Among 62 eligible children equally randomized to each group (31 in the RLRL group, 31 in the LDA group), 60 children were qualified for analysis. The mean 1-year change in AL was 0.08 mm (95% confidence interval [CI], 0.03–0.14) in the RLRL group and 0.33 mm (95% CI, 0.27–0.38) in the LDA group, with a mean difference (MD) of −0.24 mm (95% CI, −0.32 to −0.17;
P
< 0.001). The 1-year change in SER was −0.03 D (95% CI, −0.01 to −0.08) in the RLRL group and −0.60 D (95% CI, −0.7 to −0.48) in the LDA group (MD = 0.57 D; 95% CI, 0.40–0.73;
P
< 0.001). The progression of AL < 0.1 mm was 53.2% and 9.7% (
P
< 0.001) in the RLRL and LDA groups, respectively. For AL ≥ 0.36 mm, progression was 9.7% and 50.0% (
P
< 0.001) in the RLRL and LDA groups, respectively.
Conclusions
In this study, RLRL was more effective for controlling AL and myopia progression over 12 months of use compared with 0.01% atropine eye drops.
Translational Relevance
RLRL therapy significantly slows axial elongation and myopia progression compared with 0.01% atropine; thus, it is an effective alternative treatment for myopia control in children.
“…Five had increases in AL that were compatible with coordinated growth (0.023 mm ≤ ΔAL ≤ 0.052 mm) ( Table 6 , participants 2–6), and one presented with annual AL shortening (ΔAL = −0.062). The decrease in AL in either season observed in some participants and throughout the year for this one participant could be indicative of axial elongation being reversible—as previously reported in animals 67 and humans (children, 68 – 72 as well as adolescents and young adults 13 , 31 , 73 , 74 ). Nonetheless, as reported from animal studies, 67 the amount of choroidal thickening does not equal the amount of eye shortening.…”
Purpose
To investigate the diurnal rhythms in the human eye in winter and summer in southeast Norway (latitude 60°N).
Methods
Eight measures (epochs) of intraocular pressure, ocular biometry, and optical coherence tomography were obtained from healthy participants (17–24 years of age) on a mid-winter's day (
n
= 35; 6 hours of daylight at solstice) and on a day the following summer (
n
= 24; 18 hours of daylight at solstice). Participants wore an activity monitor 7 days before measurements. The epochs were scheduled relative to the individual's habitual wake and sleep time: two in the day (morning and midday) and six in the evening (every hour until and 1 hour after sleep time). Saliva was collected for melatonin. A linear mixed-effects model was used to determine significant diurnal variations, and a sinusoid with a 24-hour period was fitted to the data with a nonlinear mixed-effects model to estimate rhythmic statistics.
Results
All parameters underwent significant diurnal variation in winter and summer (
P
< 0.002). A 1-hour phase advance was observed for melatonin and ocular axial length in the summer (
P
< 0.001). The degree of change in axial length was associated with axial length phase advance (
R
2
= 0.81,
P
< 0.001) and choroidal thickening (
R
2
= 0.54,
P
< 0.001) in summer.
Conclusions
Diurnal rhythms in ocular biometry appear to be synchronized with melatonin secretion in both winter and summer, revealing seasonal variation of diurnal rhythms in young adult eyes. The association between axial length and seasonal changes in the phase relationships between ocular parameters and melatonin suggests a between-individual variation in adaptation to seasonal changes in ocular diurnal rhythms.
“…The 630 nm light used by Hung et al [ 117 ] and the 624 ± 10 nm light used by Gawne et al [ 118 ] showed significant effects on myopia control in rhesus monkeys and tree shrews. Recently, He et al found that repeated low-level red light (RLRL) therapy (650 nm, 1600 lx) could effectively improve the progression of myopia in children aged 8–13 years [ 119 ], and low-intensity, long-wavelength red light therapy (LLRT, 635 nm) inhibited myopia progression in children in an Eastern China-based cohort [ 120 ]. The effect of red light on myopia has recently gained more attention (Table 1 ).…”
Section: Controversies and Considerationsmentioning
Introduction:The aim of this article was to comprehensively review the relationship between light exposure and myopia with a focus on the effects of the light wavelength, illuminance, and contrast on the occurrence and progression of myopia. Methods: This review was performed by searching PubMed data sets including research articles and reviews utilizing the terms ''light'', ''myopia'', ''refractive error'', and ''illuminance'', and the review was concluded in November 2021. Myopia onset and progression were closely linked with emmetropization and hyperopia. To better elucidate the mechanism of myopia, some of the articles that focused on this topic were included. This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Results: The pathogenesis and prevention of myopia are not completely clear. Studies have provided evidence supporting the idea that light could affect eye growth in three ways. Changing the corresponding conditions will cause changes in the growth rate and mode of the eyes, and preliminary results have shown that FR/NIR (far red/near-infrared) light is effective for myopia in juveniles. Conclusion: This review discusses the results of studies on the effects of light exposure on myopia with the aims of providing clues and a theoretical basis for the use of light to control the development of myopia and offering new ideas for subsequent studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.